The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis
International Journal of Molecular Sciences · 09.01.2024 · 25 (2) · 817
DOI: 10.3390/ijms25020817 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.01.2024. Verfasst von André F Batista und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH/NIA.
Themen: Demenz
Abstract (Originalsprache)
As an essential component of our innate immune system, the complement system is responsible for our defense against pathogens. The complement cascade has complex roles in the central nervous system (CNS), most of what we know about it stems from its role in brain development. However, in recent years, numerous reports have implicated the classical complement cascade in both brain development and decline. More specifically, complement dysfunction has been implicated in neurodegenerative disorders, such as Alzheimer’s disease (AD), which is the most common form of dementia. Synapse loss is one of the main pathological hallmarks of AD and correlates with memory impairment. Throughout the course of AD progression, synapses are tagged with complement proteins and are consequently removed by microglia that express complement receptors. Notably, astrocytes are also capable of secreting signals that induce the expression of complement proteins in the CNS. Both astrocytes and microglia are implicated in neuroinflammation, another hallmark of AD pathogenesis. In this review, we provide an overview of previously known and newly established roles for the complement cascade in the CNS and we explore how complement interactions with microglia, astrocytes, and other risk factors such as TREM2 and ApoE4 modulate the processes of neurodegeneration in both amyloid and tau models of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- School for Mental Health and Neuroscience (MHeNs), Department of Psychiatry and Neuropsychology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
ORCID-Profile: Cynthia A Lemere
Förderung
- NIA NIH HHS
- NIH/NIA
Zitieren
APA
Batista, A. F., Khan, K. A., Papavergi, M. T., & Lemere, C. A. (2024). The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis. International Journal of Molecular Sciences, 25(2), 817. https://doi.org/10.3390/ijms25020817
Vancouver
Batista AF, Khan KA, Papavergi MT, Lemere CA. The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis. International Journal of Molecular Sciences. 2024;25(2):817. doi:10.3390/ijms25020817
BibTeX
@article{Batista2024,
author = {Batista, André F and Khan, Khyrul A and Papavergi, Maria-Tzousi and Lemere, Cynthia A},
title = {The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {2},
pages = {817},
doi = {10.3390/ijms25020817}
}
EUVIMED